Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Masimo Corporation
- Study ID
- NCT06432881
- Status
- Recruiting
Conditions
- Hypoxemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- RD SET Sensor — DEVICEAll subjects are enrolled into this arm and will have Sp02 measurements obtained.
Study Details
The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.
Key Dates
- Start date
- Jan 8, 2024
- Status verified
- May 2026
- Primary completion
- Jul 1, 2026
- Completion
- Jul 1, 2026
Study Design
- Enrollment
- 152 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: RD SET SensorAll subjects are enrolled into this arm and will have Sp02 measurements obtained.
Primary Outcome Measure
Investigation of skin pigmentation effect on performance of Masimo pulse oximetry [ Time Frame: Approximately 30 minutes ]
Central Contacts
- Chelsea Frank949-297-7000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 |
Find similar trials in Charleston, SC
By research site
Related Studies
- Postoperative Respiratory and Activity MonitoringRecruiting · University of Colorado, Denver · Aurora, Colorado
- Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU PatientsRecruiting · University of Colorado, Denver · Aurora, Colorado
- Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With HypoxemiaPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina